-
RTX sets aside $1.24 billion to resolve probes involving bribery, export controls
US weapons maker required to retain independent compliance monitors over the three-year term of the agreements.
-
Merck KGaA subsidiary nabs first-of-its-kind declination letter from DOJ
The DOJ said the business proactively disclosed information about a scheme by an insider and others to export sensitive biochemicals to China.
-
DOJ will not prosecute Proterial Cable over false safety reports as ECCP kicks in
The company earned leniency for self-reporting and showing cooperation, despite evidence its employees covered up failed safety test results.
-
DOJ pilot program offers leniency for some executive criminal tipsters
Pilot program at DOJ will give immunity to executives providing information about corporate misconduct in which they were involved.
-
Acting Assistant AG Argentieri makes key announcement at FCPA conference
Acting Assistant AG Nicole Argentieri unveiled a new resource at DOJ designed to help it better locate and prosecute FCPA cases.
-
UK reinsurance brokers settle FCPA charges with DOJ
Millions of dollars in bribes were paid to Ecuadorian government officials.
-
Biotech company avoids DOJ charges after self-reporting payment of bribes
Lifecore Biomedical, Inc.’s efforts in self-reporting FCPA violations lead to declination decision from DOJ.
-
Podcast: Julie DiMauro on the FCPA and how compliance has shifted since the pandemic
A regulatory expert and the newest addition to the GRIP team, Julie shared her insights on several key issues.